| Document |
Document Title |
|
WO/2016/181388A1 |
A wearable antenna for communicating between an external transceiver and a capsule inside the gastrointestinal tract of a user, including a printed circuit board for forming a conducting pattern on a first face and on a second face of th...
|
|
WO/2016/183040A1 |
Embodiments of the invention provide swallowable devices, preparations and methods for delivering therapeutic agents within the GI tract such as neutralizing proteins (NP) particularly antibodies which neutralize interleukins. Many embod...
|
|
WO/2016/176515A1 |
Materials and methods of using the same to improve structural integrity of a wall of a mammalian luminal organ. In an exemplary method of method for reinforcing a wall of a luminal organ, the method comprises the steps of inserting at le...
|
|
WO/2016/176211A1 |
One embodiment is a lead introducer including an outer needle, an inner needle, a splittable member, and an annular seal member. The outer needle, inner needle, and splittable member each include a body and hub. The splittable member fit...
|
|
WO/2016/172704A1 |
Drug delivery devices (1000) having a drug-permeable component and methods of making and using the same are provided. Drug delivery devices include a housing (1002) having a first (1012) and second wall (1014) structures that are adjacen...
|
|
WO/2016/168686A1 |
A glaucoma drainage device regulator (GDDR) is disclosed which comprises a membrane and a shunt tube to regulate the flow of aqueous in conjunction with different ocular (e.g., glaucoma) filtering procedures. In connection with aqueous s...
|
|
WO/2016/165593A1 |
An instrument for deep implantation in an intestinal tract comprises a medication delivery tube (1) and a fixing line (2). The medication delivery tube (1) is a flexible and bendable tube made of a polymer material, and has openings at t...
|
|
WO/2016/160658A1 |
A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primar...
|
|
WO/2016/160905A1 |
A drug-eluting balloon or stent protective device may comprise structures and functionality for protecting coatings on balloon and stent devices, isolating coatings from exposure to fluids until the precise desired moment of release from...
|
|
WO/2016/160934A1 |
Drug delivery devices include a flexible elongate body (102) having a bladder end portion (108), a kidney end portion (110), and a drug lumen (106) extending therebetween; and a drug reservoir (104) which is located at the bladder end po...
|
|
WO/2016/155671A1 |
Disclosed is a swallowable device (100, 200, 300, 500, 500', 600, 700, 800, 900, 900', 1000, 1100, 1200), comprising a housing (402, 502, 602, 702, 802, 902, 902', 1002, 1102, 1202); one or more penetration parts (520, 620, 720, 820, 920...
|
|
WO/2016/156612A1 |
The device, that can be implanted in the intestinal cavity, comprises a reactor comprising a semi-permeable or porous membrane or coating linked to a element for attachment to an intestinal or gastric wall. The reactor can be in the form...
|
|
WO/2016/156403A1 |
Described herein is a vaginal ring applicator comprising a barrel comprising a polymer and at least one friction reducing agent, wherein the barrel is a flattened cylinder having two slightly curved and opposing sides connected by two ar...
|
|
WO/2016/156664A1 |
An apparatus comprises a data processing unit (100) which receives electroencephalographic data based on a measurement of a person (110) exposed to anesthetic drug substance which has one or more estimated or measured non-zero levels of ...
|
|
WO/2016/154209A1 |
Near field communications are used to locate a radiating transponder, such as a pill swallowed by a patient. The system can be triggered to turn on and transmit a waveform to a set of antennas attached to, coupled with, or near the patie...
|
|
WO/2016/154453A1 |
Artificial salivary gland devices and assemblies are provided. The present disclosure provides artificial salivary pump/gland devices and assemblies, and related methods of use. One embodiment utilizes the interstitial/marrow fluid reser...
|
|
WO/2016/149563A1 |
Embodiments disclose uterine manipulators, dye delivery systems and fornix delineators that address several issues, such as minimizing surgical error, minimizing loss of parts inside a patients, enabling easy manipulation of a patient's ...
|
|
WO/2016/144832A1 |
Embodiments described herein relate generally to medical implant delivery apparatuses and methods. In some embodiments, an apparatus comprises a second cap, a needle hub at least partially disposed within the second cap, a pusher wire an...
|
|
WO/2016/145299A1 |
Therapy is provided to living tissue by contacting the living tissue with at least one reservoir loaded with cells or a therapeutic composition, wherein the reservoir is in fluid communication with at least one conduit that includes a re...
|
|
WO/2016/141288A1 |
A system according to the present invention provides for drug delivery without requiring the patient to maintain a drug dosage schedule. The system includes a capsule that contains a medical reservoir, a medication pump, a battery, a wir...
|
|
WO/2016/141350A1 |
A drug delivery device, method of making a drug delivery device, and method of using a drug delivery device are described. The drug delivery device may be used to treat a target area within a patient's vasculature and comprises a shell, ...
|
|
WO/2016/138796A1 |
A disposable intranasal brain-targeting drug delivery apparatus comprising an administering apparatus. The administering apparatus comprises a container (1) having a cavity and used for accommodating an agent, a catheter (2) in communica...
|
|
WO/2016/133848A2 |
Disclosed are devices, methods and surgical procedures for detecting, imaging, analyzing, diagnosing and/or treating vascular disorders and related conditions of the human and mammalian body in males and/or females. In particular embodim...
|
|
WO/2016/123027A1 |
The invention pertains to apparatuses, means and methods to promote uptake of fluids into a reservoir of an implantable drug delivery system though a porous membrane. Embodiments of the invention promote fluid uptake by creating a pressu...
|
|
WO/2016/112388A1 |
Methods and devices to affect types, proportion, quantity, distribution, or proliferation of microorganisms within a female reproductive system.
|
|
WO/2016/111642A1 |
According to embodiments of the present invention, a subcutaneous implant delivery apparatus is provided. The apparatus includes a receiving portion configured to receive a subcutaneous implantable device; and a stabilizing portion confi...
|
|
WO/2016/109512A1 |
A traceable device and procedure suitable for investigating gastrointestinal motility disorders by measuring transit time of the device as it is passed through the gastrointestinal tract of a patient. The device includes a core material ...
|
|
WO/2016/109700A1 |
In various embodiments, an implantable drug-delivery device features one or more rigid drug reservoirs from which therapeutic agents are administered and which are refilled from a flexible reservoir within the device.
|
|
WO/2016/102463A1 |
The invention relates to a product or pharmaceutical composition comprising remifentanil and propofol, or the pharmaceutically acceptable salts thereof, as a combined preparation for simultaneous use in inducing and maintaining general a...
|
|
WO/2016/102067A1 |
The present invention relates to a pharmaceutical dosage form for application to a mucous membrane, in particular to a buccal, intestinal, rectal or vaginal mucous membrane, comprising at least one sheet like, in particular film shaped, ...
|
|
WO/2016/106329A1 |
An apparatus includes a housing and a pushrod. The housing defines a delivery passage and an exit port in fluid communication with the delivery passage. At least a portion of the pushrod is movably disposed in the delivery passage. A dis...
|
|
WO/2016/099792A1 |
Various embodiments of the present disclosure include a consumable capsule containing an active ingredient in at least one compartment movably sealed by a stimuli responsive actuator, and an activation device configured to communicate wi...
|
|
WO/2016/080943A1 |
Embodiments herein describe tools, instruments and methods for aseptic loading, dispensing and/or delivering cells into an implantable device and aseptically and selectively sealing a device inside a sterile package as well as and storin...
|
|
WO/2016/074647A1 |
A uterus conformal anti-adhesion protective screen device and using method thereof, for solving problems of insecure positioning of the present anti-adhesion protective screen device. The device comprises a tube (1), and a first liquid-p...
|
|
WO/2016/075578A1 |
A delivery device includes a substrate (201) formed in a coil (200); a plurality of cavities (202) for holding an active agent, the cavities (202) disposed along a length of the substrate (201) between an inner surface (304) and an outer...
|
|
WO/2016/073596A1 |
Balloon assemblies are selectively mountable to a brachytherapy applicator, such as a tandem and ring applicator. The balloon assembly may include a balloon, an inflation port configured to selectively introduce and remove inflation flui...
|
|
WO/2016/073490A1 |
A serration balloon can have a number of different components and can be made in a number of different manners. One or more longitudinally extending members with periodic raised wedges can be attached to a medical balloon. They can be at...
|
|
WO/2016/069364A1 |
A device that uses an anatomic landmark or fiduciary point to establish a point of origin for device orientation in space is provided. The device controls the direction and depth of delivery of a needle, wire, trocar or cannula utilized ...
|
|
WO/2016/064959A1 |
The present invention generally relates to local therapies for the eye and, more particularly, to shaped controlled-release ocular implant devices, including methods for making and using such devices, for delivery of therapeutic agents t...
|
|
WO/2016/064076A1 |
Disclosed is a catheter assembly, including: an external tube member inserted into a blood vessel; a first internal tube member inserted into the blood vessel through the external tube member; a first balloon portion provided at an end s...
|
|
WO/2016/065112A1 |
A valve assembly (10, 10") is provided for reverse-flow prevention, i.e, anti-reflux flow control for associated components, such as for nutritional administration to patients. The valve assembly includes a valve body (12) including a ma...
|
|
WO/2016/064077A1 |
Disclosed is a catheter assembly, including: an external tube member inserted into a blood vessel; a first internal tube member inserted into the blood vessel through the external tube member; a first balloon portion provided at an end o...
|
|
WO/2016/056376A1 |
The present invention addresses the problem of providing a chemical ablation device that can perform, in a simple manner, a chemical ablation treatment including electric potential measurements before and after the treatment. This chemic...
|
|
WO/2016/054470A1 |
This document provides devices, systems, and methods for treating patients with wounds. For example, this document provides a multi-lumen tubular device that can deliver wound irrigation, wound suction, and medicinal treatment through th...
|
|
WO/2016/051404A1 |
An applicator device for applying a fluid substance within a body cavity includes an applicator body for insertion into the body cavity. A chamber within the applicator body holds the fluid substance. A plunger applies pressure to the fl...
|
|
WO/2016/044145A1 |
Novel systems for delivering therapeutic agents to target tissues are disclosed. The guidewire (520) and cannula (500) configurations enable rapid and repeated treatments of the target tissue without the need for subsequent imaging. The ...
|
|
WO/2016/044366A1 |
This invention discloses reservoirs, such as implants for delivering therapeutic agents, particularly large molecules such as proteins and antibodies. The reservoirs may comprise a porous silicon-based carrier material impregnated with t...
|
|
WO/2016/042641A1 |
The purpose of the present invention is to provide a system and method for administering a permeable liquid medicine, whereby: burdens both on a living body and on an operator can be reduced; a loss in the liquid medicine can be minimize...
|
|
WO/2016/040904A1 |
Drug delivery devices and methods are provided for modulating the microenvironmental pH surrounding the device. One embodiment of a drug delivery device includes an elongated annular body formed of a matrix system containing a drug dispe...
|
|
WO/2016/040610A1 |
Vaginal dilators include an incrementally inflatable, optionally curved balloon mounted onto a flexible, elongated shaft having a soft rubber tip.
|
